Steven J. Rice - 23 Aug 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Chief Administrative Officer
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 23 Aug 2021
Net transactions value: -$372,400
Form type: 4
Filing time: 24 Aug 2021, 18:44:57 UTC
Previous filing: 29 Jun 2021
Next filing: 02 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$127,600	+10,000	+50%	$12.76	30,000	23 Aug 2021	Direct
transaction	VIR	Common Stock	Sale	$500,000	-10,000	-33%	$50.00^*	20,000	23 Aug 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Employee Stock Option (Right to Buy)	Options Exercise	$0	-10,000	-2.3%	$0.000000	434,441	23 Aug 2021	Common Stock	10,000	$12.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
F2	1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.